FDA Approves Bristol Oral Treatment for Advanced Multiple Myeloma

The FDA has approved a new oral treatment by Bristol for advanced multiple myeloma, introducing a new class of medicine for the blood cancer.

• The FDA approved a Bristol oral treatment for advanced multiple myeloma.
• The approval marks the debut of a new class of medicine for this blood cancer.